Fengfeng Pan
Overview
Explore the profile of Fengfeng Pan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
23
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang Y, Zhu L, He K, Cui L, Pan F, Guan Y, et al.
J Alzheimers Dis
. 2025 Jan;
103(4):1102-1111.
PMID: 39791247
Background: Urinary formic acid (FA) has been reported to be a biomarker for Alzheimer's disease (AD). However, the association between FA and pathological changes in memory clinic patients is currently...
2.
Chen T, Pan F, Huang Q, Xie G, Chao X, Wu L, et al.
Nat Commun
. 2024 May;
15(1):3796.
PMID: 38714706
The metabolic implications in Alzheimer's disease (AD) remain poorly understood. Here, we conducted a metabolomics study on a moderately aging Chinese Han cohort (n = 1397; mean age 66 years)....
3.
Huang L, Li Q, Lu Y, Pan F, Cui L, Wang Y, et al.
Gen Psychiatr
. 2024 Feb;
37(1):e101310.
PMID: 38313393
Alzheimer's disease (AD) is a common cause of dementia, characterised by cerebral amyloid-β deposition, pathological tau and neurodegeneration. The prodromal stage of AD (pAD) refers to patients with mild cognitive...
4.
Li J, Huang Q, Qi N, He K, Li S, Huang L, et al.
J Cereb Blood Flow Metab
. 2024 Jan;
44(7):1199-1207.
PMID: 38295871
A newly developed SV2A radiotracer, F-SynVesT-1, was used in this study to investigate synaptic density and its association with Alzheimer's disease (AD) "A/T/N" biomarkers. The study included a cohort of...
5.
Pan F, Lu Y, Huang Q, Xie F, Yang J, Guo Q
Transl Neurodegener
. 2023 Aug;
12(1):39.
PMID: 37596644
No abstract available.
6.
Pan F, Wang Y, Wang Y, Wang X, Guan Y, Xie F, et al.
Neurobiol Aging
. 2023 Jul;
130:84-92.
PMID: 37481959
Conflicting findings exist regarding the differences in amyloid burden and cognitive performance based on sex and apolipoprotein E (APOE) genotype. This study aimed to investigate the brain amyloid-β (Aβ) burden...
7.
Pan F, Huang Y, Cai X, Wang Y, Guan Y, Deng J, et al.
Commun Med (Lond)
. 2023 May;
3(1):65.
PMID: 37165172
Background: Accurate prediction of cerebral amyloidosis with easily available indicators is urgently needed for diagnosis and treatment of Alzheimer's disease (AD). Methods: We examined plasma Aβ42, Aβ40, T-tau, P-tau181, and...
8.
Wang Y, Pan F, Xie F, He R, Guo Q
Front Aging Neurosci
. 2022 Feb;
14:820385.
PMID: 35221998
Urine-based formaldehyde has been reported to be a potential biomarker for Alzheimer's disease (AD). However, there is a lack of research about the correlation between urine formaldehyde and cognitive abilities...